Nutraceuticals CDMO Market To Hit Value $67.83 Billion By 2030 |Grand View Research, Inc.

Author : Mrudula Karmarkar | Published On : 05 Jan 2024

San Francisco, 05 January 2024: The Report Nutraceuticals CDMO Market Size, Share & Trends Analysis Report By Dosage Form (Tablets, Softgel), By Services (Product Formulation & Development, Research & Development), By Company Size, By Region, And Segment Forecasts, 2023 - 2030

The global nutraceuticals CDMO market size is expected to reach USD 67.83 billion by 2030, expanding at 7.7% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. Rising awareness of nutraceuticals products, demand for nutraceuticals with medical benefits, and technological advancement are the some of the major factors driving the market growth.

Furthermore, increasing demand for organic and natural products is expected to drive market growth. CDMOs are responding to this demand by providing services related to sustainable manufacturing practices, natural ingredient sourcing, and certifications for organic product manufacturing. Moreover, increasing technological advancements to improve manufacturing processes and enhance product quality is anticipated to create growth opportunities for market growth. The technological advancement includes the adoption of new delivery systems, such as microencapsulation, and nano-emulsions, to improve the bioavailability and stability of nutraceutical ingredients.

Nutraceutical CDMOs are witnessing an increasing demand for customized solutions to meet the specific requirements of individual customers. Key companies are providing personalized nutrition solutions based on a person's unique health and well-being requirements. This is accomplished by lifestyle assessments, genetic testing, and personalized recommendations. Moreover, companies are exploring new delivery systems for nutraceuticals, such as nanoparticle delivery and liposome encapsulation to enhance the efficacy of the products.

On the other hand, key companies in the market undertaking various strategic initiatives such as partnerships, new service launches, mergers and acquisitions, and regional expansion to strengthen their market presence. For instance, in August 2022, Zerion Pharma entered into a partnership with Hovione to cover the use of the Dispersome platform in nutraceuticals. As part of this initiative, Hovione and ZERION will use the Dispersome technology to scale up and create commercial formulations of the antioxidant. Moreover, in October 2023, Sirio Pharma, a China-based nutraceutical contract development organization launched a plant-based nutraceutical service package. The company is actively promoting its integrated solutions for plant-based nutraceuticals through the event.

Request sample report of Nutraceuticals CDMO Market@ https://www.grandviewresearch.com/industry-analysis/nutraceuticals-cdmo-market-report/request/rs1

Nutraceuticals CDMO Market Report Highlights

  • Based on dosage forms, the tablets & capsules segment dominated the market share of 61.43% in 2022. The growth of the segment is attributed to the formulation flexibility it offers to developers. Capsules are available in different sizes (000 to 5), offering developers with various dosing options
  • On the other hand, the soft gel segment is expected to hold a significant market share in the coming years. For individuals who have trouble swallowing tablets or are averse to the idea of injections, the soft gel remains a preferred option because they are simple to take
  • Based on services, manufacturing, and packaging captured a major share in 2022. Manufacturing requires substantial equipment, infrastructure, and skilled staff. By outsourcing these functions to CDMOs, nutraceutical companies can minimize capital expenses and operational expenses associated with maintaining in-house production capabilities
  • Mid-sized companies held a major share of the company size segment in 2022. Mid-sized companies can provide specialized services based on the unique requirements of their customers. Mid-sized CROs can quickly adapt to changing client needs and offer individualized solutions
  • North America dominated the market in 2022 due to factors such as rising awareness regarding nutraceuticals,changing lifestyles, and growing health concerns among consumers
  • Some of the major players include Catalent Inc.; Lonza; NUTRASCIENCE LABS; Robinson Pharma, Inc.; Health Wright Products, Inc.; Innovations in Nutrition + Wellness; among others.

Nutraceuticals are gaining popularity due to the growing demand for organic and natural products that support health and wellness. The advancement in technology, such as the adoption of AI, Robotic Process Automation (RPA), 3-D printing trends, Virtual Reality, and Augmented Reality, increase efficiency during the manufacturing and product formulation process. 3D printing techniques in the nutraceutical industry have given rise to new ventures to make better drug delivery. The technology allows the utilization of customizable ingredients to produce products that are uniquely designed with specific ingredients.

List of Key Players in the Nutraceuticals CDMO Market

  • Catalent Inc.
  • Lonza
  • NUTRASCIENCE LABS
  • Robinson Pharma, Inc.
  • Health Wright Products, Inc.
  • Innovations in Nutrition + Wellness
  • INPHARMA S.p.A.
  • Aenova Group
  • NutraPakUSA
  • SFI Health